ALX Oncology Holdings Cash from Financing (TTM) Insights

ALX Oncology Holdings Inc (ALXO)

15.80 +0.44 (+2.83%) USD | NASDAQ | May 06, 16:00

15.78 -0.02 (-0.09%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	59.29M
September 30, 2023	9.619M
June 30, 2023	9.594M
March 31, 2023	9.673M
December 31, 2022	9.86M
September 30, 2022	0.89M
June 30, 2022	1.465M
March 31, 2022	1.774M
December 31, 2021	2.472M

Date	Value
September 30, 2021	190.31M
June 30, 2021	360.17M
March 31, 2021	358.67M
December 31, 2020	462.88M
September 30, 2020	280.45M
June 30, 2020	110.15M
March 31, 2020	120.35M
December 31, 2019	15.36M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.89M

Minimum

Sep 2022

462.88M

Maximum

Dec 2020

117.82M

Average

15.36M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks